Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of PPI Response in Eosinophilic Esophagitis
NCT01479231Phase 2Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Mar 2012
- Primary completion
- Mar 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dexlansoprazole in eosinophilic esophagitis (EoE), sponsored by Mayo Clinic. Planned start Mar 2012; status: withdrawn.
02
Drugs
dexlansoprazole
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT01479231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479231.